Join us

Oncoinvent presents a unique opportunity to join an expanding pharmaceutical start-up with both R&D and production established in-house which enables both hands-on lab work as well as working with external partners.

The company has solid owners and is currently in late preclinical phase with its lead product (Radspherin®) which is produced in Nydalen.

The candidates should be looking for the energy in a start up with the ambition to make a difference. Successful candidates should be flexible, team-oriented yet able to work independently, and be analytical and results oriented.

If you would like to send us an open application, please send your application and résumé to


Engineer Quality Control

Oncoinvent AS is looking for an Engineer to strengthen the Quality Control team at the manufacturing facility in Oslo. The position is an exciting opportunity to work in an innovative and dynamic company and participate in the development of novel pharmaceuticals.

The successful candidate will, together with the Quality Control team be responsible for quality control of raw materials, intermediates and drug product (Radspherin®) and for environmental monitoring of the cleanrooms.

Key responsibilities:

  • Routine testing of raw materials, intermediates and finished product.
  • Perform Environmental Monitoring, trending and reporting.
  • Participate in the validation of test methods.
  • Investigate deviations and closing of the records in a timely fashion.
  • Resolve, in collaboration with the QC, QA and production team, out-of-specification or unexpected results and analytical and product problems.
  • Maintain and troubleshoot analytical instrumentation as needed. Performs audits on equipment periodically to verify proper calibration and use.
  • Record and report results of analysis in accordance with prescribed lab procedures and systems.
  • Writing of SOPs and other instructional documents.


Qualifications and experience:

The holder of the Senior Research Scientist Drug Development position should have the following documented qualifications and experience:

  • D. in chemistry, biology, biochemistry, biotechnology
  • Minimum 5 years practical, hands-on experience in experimental research
  • Experience in drug development, preferentially within the field of radiopharmaceuticals
  • Experience in publication in peer-reviewed journals
  • Strong problem-solving, troubleshooting and written/oral communication skills
  • A successful candidate will have to be able to work in a multidisciplinary team while being able to plan and perform practical work independently


The holder of this position should have the following documented qualifications and experience:

  • B.Sc. in biology or analytical chemistry.
  • Relevant experience in microbiological methods, microbial identification systems. Quality Control of radiopharmaceuticals/pharmaceuticals.
  • Working knowledge in Norwegian and English.
  • Familiarity with cGMP regulation.
  • A successful candidate will have to be able to work in a multidisciplinary team while being able to plan and perform practical work independently.


The holder of this position will be based at Oncoinvent AS, Gullhaugveien 7, 0484 Oslo. The position will report to the Head of Quality.

About Oncoinvent

Oncoinvent is a privately held Norwegian company based in Nydalen, Oslo. The company is committed to developing novel, innovative products to provide better treatment options for cancer patients. The Oncoinvent team consists of 27 employees and the company is growing. In December 2017 Oncoinvent finished building a state-of-the-art manufacturing facility to produce drug product intended for use pre-clinical and early phase clinical trials.

Application deadline: 31. Oct. 2020


Gro Elisabeth Hjellum, Head of Quality Control, CMC Coordinator

Mobile: +47 97 98 30 92


Jan Alan Alfheim

Chief Executive Officer

+47 464 40 045

Jan A. Alfheim is a business executive with over thirty years’ experience bringing product ideas and technology to the chemical and pharmaceutical markets, from product concept inception through discovery and development phases to final marketing campaign and launch.

With experience in research, project management, business development & partnering, company start-ups, and product launches, Alfheim comes from Nordic Nanovector ASA where he was Chief Executive Officer from 2011 until 2014 and Chief Operating Officer from 2014 to 2016. Prior to working at Nordic Nanovector, he has held various senior roles including Chief Business Officer at Clavis Pharma, President of StemPath Inc, Director of Business Development at Neurochem Inc and Project Director at Nycomed Imaging. Mr. Alfheim holds a MSc from Concordia University and a MBA from McGill University.